| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 01/29/2003 | CN1393259A Prescription and preparing process of Chinese patent medicine for preventing and treating postoperative adhesion |
| 01/24/2003 | CA2394209A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | US20030018357 Wound closure system and methods |
| 01/23/2003 | US20030018193 Beta-alanine derivatives and their use as receptor anatgonists |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017151 Receptor Activator of NF-kappa B antagonists; treatment of medical conditions that require the formation of new bone. |
| 01/22/2003 | EP1277746A2 N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions thereof |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276488A1 Use of lactic acid bacterium for the treatment of peritonitis |
| 01/21/2003 | US6509443 Amino acid residue located at position 63 of native-sequence human Insulin like Growth Factor-I is replaced with an alanine residue or amino acid residues at positions 1 and 70 are replaced with serine and valine respectively |
| 01/21/2003 | US6509318 TGF-B inhibitors and methods |
| 01/21/2003 | US6509028 Methods and compositions for treating pain of the mucous membrane |
| 01/16/2003 | WO2003004098A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 01/16/2003 | US20030013726 Sleep disorders; anxiolytic agents; muscle disease |
| 01/16/2003 | CA2452372A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 01/16/2003 | CA2394010A1 Novel n-benzylpiperazine derivatives, their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274692A1 Quinazoline compounds |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/14/2003 | US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | US20030007968 Administering bone marrow cells with lymphyocytes removed; then busulfan |
| 01/09/2003 | US20030007954 Cardiovascular disorder; strokes; gene therapy |
| 01/03/2003 | WO2003000344A1 Use of phospholipids for the prevention 0f surgical adhesions |
| 01/03/2003 | WO2002070594A3 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/02/2003 | US20030004110 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/02/2003 | EP1267894A2 Viscoelastics for use in middle ear surgery |
| 01/02/2003 | EP1267886A2 Vitamin d compounds used to stabilize kidney transplants |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 12/27/2002 | WO2002102428A1 Synechia inhibitory material |
| 12/26/2002 | US20020198571 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 12/26/2002 | US20020198570 Apparatus for indirectly stimulating the vagus nerve with an electrical field |
| 12/26/2002 | US20020198266 Skin remedy, which allows gas transportation therethrough |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020192288 Methods and compositions for treating pain of the mucous membrane |
| 12/18/2002 | EP1266012A2 Proteases |
| 12/18/2002 | EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 12/18/2002 | EP1265853A1 Carboxylic acid derivatives as ip antagonists |
| 12/18/2002 | CN1385153A Preparation process for surfacce anesthesia cream |
| 12/18/2002 | CN1385152A Antiadhesion agent for preventing abdominal organs from adhesion |
| 12/17/2002 | US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 12/17/2002 | US6495563 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 12/12/2002 | US20020188134 Pharmaceutical compositions |
| 12/11/2002 | EP1263959A1 Antibodies to human cd154 |
| 12/11/2002 | EP1263929A2 Artificial bone chips, methods for the production thereof and their use |
| 12/11/2002 | EP1263761A2 Compounds for pdt |
| 12/11/2002 | EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 12/11/2002 | CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions |
| 12/10/2002 | US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage |
| 12/10/2002 | US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 12/05/2002 | WO2002097030A2 Peptides derived from neural thread proteins and their medical use |
| 12/05/2002 | WO2002096366A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 12/05/2002 | WO2002053110A3 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 12/05/2002 | WO2002047728A3 Treatment of posterior capsule opacification |
| 12/05/2002 | US20020183764 Embolic materials |
| 12/05/2002 | US20020183237 Methods of performing vagal-induced asystole |
| 12/05/2002 | US20020182650 Inhibitors of binding between proteins and macromolecular ligands |
| 12/05/2002 | US20020182187 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 12/05/2002 | US20020182185 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/05/2002 | CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 12/05/2002 | CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/04/2002 | EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 12/04/2002 | EP1261579A1 Dehydroamino acids |
| 12/04/2002 | EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 12/04/2002 | EP1261329A2 Il-8 receptor antagonists |
| 12/04/2002 | CN1382461A Instant Chinese medicine for treating intestinal adhesion and its preparing process |
| 12/04/2002 | CN1095379C Chinese medicine for detoxicating wound and its preparing process |
| 12/03/2002 | US6489367 Semifluorinated alkanes and the use thereof |
| 12/03/2002 | US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications |
| 12/03/2002 | US6488944 1, 1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
| 11/28/2002 | WO2002094019A1 Highly purified antiendotoxin compound |
| 11/28/2002 | WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 11/27/2002 | EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 11/27/2002 | EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 11/27/2002 | EP1259241A1 The use of scopolamine salts |
| 11/27/2002 | CN1382058A Method to enhance healing of sternum after sternotomy |
| 11/26/2002 | US6486212 Semifluorinated alkanes and the use thereof |
| 11/21/2002 | WO2002092075A2 Therapeutic delivery of carbon monoxide |
| 11/21/2002 | WO2002092016A2 Therapeutic use of rank antagonists |
| 11/21/2002 | WO2002043785A3 Intraocular implants for preventing transplant rejection in the eye |
| 11/21/2002 | CA2447518A1 Therapeutic use of rank antagonists |
| 11/21/2002 | CA2447275A1 Therapeutic delivery of carbon monoxide |
| 11/20/2002 | EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 11/20/2002 | EP0871458B1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 11/19/2002 | US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 11/14/2002 | WO2002090530A2 Kinases and phosphatases |
| 11/14/2002 | WO2002089807A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection |
| 11/14/2002 | WO2002089675A2 Wound closure system and methods |
| 11/14/2002 | US20020169144 Angiogenesis inhibition |
| 11/14/2002 | US20020169142 Viscoelastics for use in middle ear surgery |
| 11/14/2002 | CA2435142A1 Kinases and phosphatases |